Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Commentary

Research Type: Commentary

Sort 1 results by:

Filter Applied. Clear All

Latest Posts

July 20, 2026 Fact Sheet: Medical Indications for Separating a Mother and Her Unborn Child Fact Sheet: Medical Indications for Separating a Mother and Her Unborn Child July 20, 2026 Abortion Reporting: Wyoming (2025) Abortion Reporting: Wyoming (2025) July 20, 2026 Abortion Reporting: South Dakota (2025) Abortion Reporting: South Dakota (2025)
Reset All Filters
Stories of Premature Births, Anomalies Involving Fetal Surgery and Perinatal Hospice Sorted by Diagnosis
Fetal Development

Stories of Premature Births, Anomalies Involving Fetal Surgery and Perinatal Hospice Sorted by Diagnosis

The following is a compilation of public stories shared by families who have been affected by a prenatal diagnosis of fetal anomaly or very premature birth. This page is sorted by diagnosis.

The Impact of Chemical Abortion by Mail
Maternal & Public Health

The Impact of Chemical Abortion by Mail

Due to the COVID-19 pandemic, the U.S. abortion industry has undergone significant changes. The Food and Drug Administration (FDA) regulates mifepristone, the more dangerous first drug of the two-part chemical abortion cocktail, via a Risk Evaluation and Mitigation Strategy (REMS), which limits how the drug can be dispensed. After years of fighting these safety standards, the abortion industry took advantage of the pandemic to obtain a court order in July 2020 blocking the requirement that mifepristone be administered in person, a key element of the REMS.

Cell Lines Used for Viral Vaccine Production
Fetal Tissue, Stem Cells & Bioethics

Cell Lines Used for Viral Vaccine Production

Vaccines Licensed for Use in the United States by the Food and Drug Administration (FDA)

COVID-19, Nursing Homes, and the Need to Protect the Elderly
Maternal & Public Health

COVID-19, Nursing Homes, and the Need to Protect the Elderly

In early 2020 news began circulating that a life-threatening respiratory illness was sweeping across the world and had made its way to the United States. Reactions to the severity of the problem varied, but most jurisdictions seemed underprepared to deal with how COVID-19 would impact long-term care facilities, specifically nursing homes.

Update: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines
Maternal & Public Health

Update: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines

Accurate information about the development and production of COVID-19 vaccines is essential, especially because many proposed candidates use newer molecular technologies for production of a viral vaccine.  One concern regarding the ethical assessment of viral vaccine candidates is the potential use of abortion-derived cell lines in the development, production or testing of a vaccine.  This analysis utilizes data from the primary scientific literature when available, along with data from clinical trial documents, reputable vaccine tracking websites, and published commercial information.1  It is the hope that by providing accurate data, recipients can make well-informed decisions regarding vaccine choices.

Designing Babies: Science, Ethics, and Policies of a Post-Genomic Era
Fetal Tissue, Stem Cells & Bioethics

Designing Babies: Science, Ethics, and Policies of a Post-Genomic Era

At the Center for Bioethics and Human Dignity annual summer conference "Bioethics in Real Life,” Dr. David Prentice and Dr. Tara Sander Lee presented a workshop entitled Designing Babies: Science, Ethics, and Policies of a Post-Genomic Era. Scientific advancements in the fields of genetics, molecular diagnosis, and genetic engineering were introduced so that participants could better understand the benefits, risks, limitations, policies, and potential impact on society. The ethics were carefully evaluated and discussed.

Top 7 quotes from dissenting opinions in the June Medical abortion case
Life & the Law

Top 7 quotes from dissenting opinions in the June Medical abortion case

On June 29, 2020 the U.S. Supreme Court ruled 5-4 against a Louisiana law requiring abortionists to have admitting privileges at a hospital within 30 miles of where they perform the abortion. Justices Thomas, Alito, Gorsuch, and Kavanaugh dissented, with each writing separate dissenting opinions. Justice Gorsuch joined all of Justice Alito’s dissenting opinion and Justice Thomas and Justice Kavanaugh joined parts of it. Here are 7 of the top quotes from today’s dissenting opinions.

After June Medical ruling, meaning of Hellerstedt legal standard remains open question
Life & the Law

After June Medical ruling, meaning of Hellerstedt legal standard remains open question

The Supreme Court's ruling today in the June Medical case does not answer the question whether the free-form balancing test required by the 2016 Hellerstedt decision "supplants" or "supplements" the undue burden test from Casey.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image